| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.096 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |